Source:New Atlas | New Tech|By:Rich Handy|Date:03/18/2025, 6:22:00 PM
Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, designed to hinder the SARS-CoV-2 virus’s ability to replicate. Clinical trials moved quickly, and by the end of the year…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.